CompletedNCT03971279
Dexamethasone Intravitreal Implant (Ozurdex®) for Recurrent Vogt-Koyanagi-Harada (VKH) Disease Posterior Uveitis
Studying Posterior uveitis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Benha University
- Principal Investigator
- Tarek ElhamakyBenha university faculty of medicine , INMC
- Intervention
- Dexamethasone Ophthalmic implant(drug)
- Enrollment
- 16 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2017 – 2019
Study locations (1)
- INMC, Abu Dhabi, United Arab Emirates
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT03971279 on ClinicalTrials.gov